Aegerion (AEGR) Falls: Stock Loses 7.3%

Zacks

Aegerion Pharmaceuticals, Inc. (AEGR) saw a big move last session, as the company’s shares fell by over 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session.

This breaks the recent trend of the company, as the stock is now trading below the volatile price range of $62.10 to $68.40 in the past one-month time frame.

The biopharmaceutical company has seen a flat track record when it comes to current year estimate revisions over the past few weeks. None of the estimates were revised on either side and the consensus for earnings hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch of this firm in the near future, and especially on earnings estimates following the recent slump.

Aegerion currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the biopharmaceutical sector include Alexion Pharmaceuticals, Inc. (ALXN), Biogen Idec Inc. (BIIB) and Acceleron Pharma, Inc. (XLRN). While Alexion holds a Zacks Rank #1 (Strong Buy), Biogen and Acceleron carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



AEGERION PHARMACEUTICALS INC (AEGR): Free Stock Analysis Report

ALEXION PHARMACEUTICALS INC (ALXN): Free Stock Analysis Report

BIOGEN IDEC INC (BIIB): Free Stock Analysis Report

ACCELERON PHARMA INC (XLRN): Free Stock Analysis Report


Zacks Investment Research

Rates

View Comments (0)